Geron Corp (NASDAQ: GERN) started the day on Thursday, with a price decrease of -0.96% at $4.11, before settling in for the price of $4.15 at the close. Taking a more long-term approach, GERN posted a 52-week range of $1.64-$5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 46.26% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -16.08%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.25%. This publicly-traded company’s shares outstanding now amounts to $602.80 million, simultaneously with a float of $552.62 million. The organization now has a market capitalization sitting at $2.48 billion. At the time of writing, stock’s 50-day Moving Average stood at $4.35, while the 200-day Moving Average is $3.73.
Geron Corp (GERN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Geron Corp’s current insider ownership accounts for 8.32%, in contrast to 69.86% institutional ownership. According to the most recent insider trade that took place on Jul 08 ’24, this organization’s EVP, Chief Operating Officer sold 674,348 shares at the rate of 4.56, making the entire transaction reach 3,073,004 in total value, affecting insider ownership by 0. Preceding that transaction, on Jun 10 ’24, Company’s EVP, Chief Medical Officer sold 287,900 for 4.63, making the whole transaction’s value amount to 1,334,129. This particular insider is now the holder of 0 in total.
Geron Corp (GERN) Earnings and Revenue Records
Geron Corp’s EPS decrease for this current 12-month fiscal period is -6.25% and is forecasted to reach -0.12 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.00% through the next 5 years, which can be compared against the -16.08% growth it accomplished over the previous five years trading on the market.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Let’s observe the current performance indicators for Geron Corp (GERN). It’s Quick Ratio in the last reported quarter now stands at 3.60. The Stock has managed to achieve an average true range (ATR) of 0.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1808.39.
In the same vein, GERN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.36, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.12 at the market close of one year from today.
Technical Analysis of Geron Corp (GERN)
If we take a close look at the recent performances of Geron Corp (NASDAQ: GERN), its last 5-days Average volume was 5.19 million that shows plunge from its year to date volume of 10.36 million. During the previous 9 days, stock’s Stochastic %D was recorded 72.72% While, its Average True Range was 0.17.
Raw Stochastic average of Geron Corp (GERN) in the period of the previous 100 days is set at 16.10%, which indicates a major fall in contrast to 55.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 36.17% that was lower than 46.82% volatility it exhibited in the past 100-days period.
